vs
AeroVironment Inc（AVAV）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是AeroVironment Inc的1.3倍（$622.0M vs $472.5M），Royalty Pharma plc净利率更高（34.4% vs -3.6%，领先38.1%），AeroVironment Inc同比增速更快（181.9% vs 4.8%），过去两年AeroVironment Inc的营收复合增速更高（59.1% vs 4.6%）
AeroVironment是1971年由人力飞机设计师保罗·麦克里迪创立的美国国防科技企业，总部位于弗吉尼亚州阿灵顿，专注于自主系统、反无人机系统及航天系统的研发制造，为美国国防部及多国军方供应渡鸦、弹簧刀、黄蜂、美洲狮等系列中小型无人机产品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AVAV vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.3倍
$472.5M
营收增速更快
AVAV
高出177.1%
4.8%
净利率更高
RPRX
高出38.1%
-3.6%
两年增速更快
AVAV
近两年复合增速
4.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $472.5M | $622.0M |
| 净利润 | $-17.1M | $214.2M |
| 毛利率 | 22.0% | — |
| 营业利润率 | -6.4% | 62.4% |
| 净利率 | -3.6% | 34.4% |
| 营收同比 | 181.9% | 4.8% |
| 净利润同比 | -875.1% | 2.9% |
| 每股收益（稀释后） | $-0.34 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAVRPRX
| Q4 25 | $472.5M | $622.0M | ||
| Q3 25 | $454.7M | $609.3M | ||
| Q2 25 | $275.1M | $578.7M | ||
| Q1 25 | $167.6M | $568.2M | ||
| Q4 24 | $188.5M | $593.6M | ||
| Q3 24 | $189.5M | $564.7M | ||
| Q2 24 | $197.0M | $537.3M | ||
| Q1 24 | $186.6M | $568.0M |
净利润AVAVRPRX
| Q4 25 | $-17.1M | $214.2M | ||
| Q3 25 | $-67.4M | $288.2M | ||
| Q2 25 | $16.7M | $30.2M | ||
| Q1 25 | $-1.8M | $238.3M | ||
| Q4 24 | $7.5M | $208.2M | ||
| Q3 24 | $21.2M | $544.0M | ||
| Q2 24 | $6.0M | $102.0M | ||
| Q1 24 | $13.9M | $4.8M |
毛利率AVAVRPRX
| Q4 25 | 22.0% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 37.7% | — | ||
| Q4 24 | 39.1% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 38.4% | — | ||
| Q1 24 | 36.1% | — |
营业利润率AVAVRPRX
| Q4 25 | -6.4% | 62.4% | ||
| Q3 25 | -15.2% | 70.1% | ||
| Q2 25 | 5.0% | 36.3% | ||
| Q1 25 | -1.8% | 94.0% | ||
| Q4 24 | 3.7% | 60.9% | ||
| Q3 24 | 12.2% | — | ||
| Q2 24 | 3.0% | 50.2% | ||
| Q1 24 | 7.7% | -13.0% |
净利率AVAVRPRX
| Q4 25 | -3.6% | 34.4% | ||
| Q3 25 | -14.8% | 47.3% | ||
| Q2 25 | 6.1% | 5.2% | ||
| Q1 25 | -1.0% | 41.9% | ||
| Q4 24 | 4.0% | 35.1% | ||
| Q3 24 | 11.2% | 96.3% | ||
| Q2 24 | 3.1% | 19.0% | ||
| Q1 24 | 7.4% | 0.8% |
每股收益（稀释后）AVAVRPRX
| Q4 25 | $-0.34 | $0.49 | ||
| Q3 25 | $-1.44 | $0.67 | ||
| Q2 25 | $0.59 | $0.07 | ||
| Q1 25 | $-0.06 | $0.55 | ||
| Q4 24 | $0.27 | $0.46 | ||
| Q3 24 | $0.75 | $1.21 | ||
| Q2 24 | $0.18 | $0.23 | ||
| Q1 24 | $0.50 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $588.5M | $618.7M |
| 总债务越低越好 | $747.5M | $9.0B |
| 股东权益账面价值 | $4.4B | $9.7B |
| 总资产 | $5.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AVAVRPRX
| Q4 25 | $588.5M | $618.7M | ||
| Q3 25 | $685.8M | $938.9M | ||
| Q2 25 | $40.9M | $631.9M | ||
| Q1 25 | $47.0M | $1.1B | ||
| Q4 24 | $69.0M | $929.0M | ||
| Q3 24 | $81.2M | $950.1M | ||
| Q2 24 | $73.3M | $1.8B | ||
| Q1 24 | $107.7M | $843.0M |
总债务AVAVRPRX
| Q4 25 | $747.5M | $9.0B | ||
| Q3 25 | $747.5M | $8.9B | ||
| Q2 25 | $30.0M | $8.0B | ||
| Q1 25 | $25.0M | $7.6B | ||
| Q4 24 | $15.0M | $7.6B | ||
| Q3 24 | $17.5M | $7.6B | ||
| Q2 24 | $28.0M | $7.6B | ||
| Q1 24 | $40.0M | $6.1B |
股东权益AVAVRPRX
| Q4 25 | $4.4B | $9.7B | ||
| Q3 25 | $4.4B | $9.6B | ||
| Q2 25 | $886.5M | $9.5B | ||
| Q1 25 | $861.1M | $9.8B | ||
| Q4 24 | $858.4M | $10.3B | ||
| Q3 24 | $845.5M | $10.3B | ||
| Q2 24 | $822.7M | $9.8B | ||
| Q1 24 | $813.0M | $9.9B |
总资产AVAVRPRX
| Q4 25 | $5.6B | $19.6B | ||
| Q3 25 | $5.6B | $19.3B | ||
| Q2 25 | $1.1B | $18.3B | ||
| Q1 25 | $1.0B | $17.6B | ||
| Q4 24 | $1.0B | $18.2B | ||
| Q3 24 | $999.2M | $18.0B | ||
| Q2 24 | $1.0B | $17.7B | ||
| Q1 24 | $980.3M | $16.1B |
负债/权益比AVAVRPRX
| Q4 25 | 0.17× | 0.92× | ||
| Q3 25 | 0.17× | 0.93× | ||
| Q2 25 | 0.03× | 0.84× | ||
| Q1 25 | 0.03× | 0.78× | ||
| Q4 24 | 0.02× | 0.74× | ||
| Q3 24 | 0.02× | 0.74× | ||
| Q2 24 | 0.03× | 0.78× | ||
| Q1 24 | 0.05× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-45.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-55.9M | — |
| 自由现金流率自由现金流/营收 | -11.8% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-240.7M | — |
8季度趋势，按日历期对齐
经营现金流AVAVRPRX
| Q4 25 | $-45.1M | $827.1M | ||
| Q3 25 | $-123.7M | $702.6M | ||
| Q2 25 | $-264.0K | $364.0M | ||
| Q1 25 | $-25.8M | $596.1M | ||
| Q4 24 | $-3.6M | $742.5M | ||
| Q3 24 | $28.4M | $703.6M | ||
| Q2 24 | $-11.7M | $658.2M | ||
| Q1 24 | $52.6M | $664.6M |
自由现金流AVAVRPRX
| Q4 25 | $-55.9M | — | ||
| Q3 25 | $-146.5M | — | ||
| Q2 25 | $-8.8M | — | ||
| Q1 25 | $-29.6M | — | ||
| Q4 24 | $-8.7M | — | ||
| Q3 24 | $22.9M | — | ||
| Q2 24 | $-20.8M | — | ||
| Q1 24 | $48.8M | — |
自由现金流率AVAVRPRX
| Q4 25 | -11.8% | — | ||
| Q3 25 | -32.2% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -17.7% | — | ||
| Q4 24 | -4.6% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | -10.5% | — | ||
| Q1 24 | 26.1% | — |
资本支出强度AVAVRPRX
| Q4 25 | 2.3% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 2.0% | — |
现金转化率AVAVRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | -0.02× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -0.48× | 3.57× | ||
| Q3 24 | 1.34× | 1.29× | ||
| Q2 24 | -1.93× | 6.45× | ||
| Q1 24 | 3.79× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAV
| Services | $130.2M | 28% |
| Cost Plus | $95.8M | 20% |
| Uncrewed Aircraft Systems | $89.8M | 19% |
| Space And Directed Energy | $53.2M | 11% |
| Non U.s.Government | $42.2M | 9% |
| TM | $31.9M | 7% |
| Other | $30.7M | 7% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
